Status:
COMPLETED
Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer
Lead Sponsor:
Institut Jean-Godinot
Conditions:
Breast Cancer Female
Joint Pain
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Interventional, randomised, prospective, monocentric study
Detailed Description
Interventional, randomised, prospective, monocentric study Primary objective : Demonstrate the interest of the homeopathic Protocol to reduce the onset or aggravation of joint pain as a result of th...
Eligibility Criteria
Inclusion
- menopausal patient
- achieved histologically confirmed non-metastatic breast cancer with positive hormonal receptors
- starting an adjuvant anti-hormonal treatment with an AI
- patient benefiting from a social protection scheme
- patient mastering the French language -signature of free and informed consent -
Exclusion
- patient whose treatment with chemotherapy or radiotherapy is ongoing or anticipated during the theoretical period of the study or patient who has completed her chemotherapy treatment within a period of less than 4 weeks prior to the inclusion visit
- patient with proven inflammatory rheumatism already diagnosed with rheumatoid arthritis, lupus, psoriatic rheumatism, ankylosing spondylitis -concomitant treatment with other complementary medicines (excepted Vitamin D), unless the treatment has been stable for at least 1 month.
- current treatment with narcotic drugs or corticosteroids
- patient with overexpressing breast cancer HER2
Key Trial Info
Start Date :
September 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2022
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04408560
Start Date
September 13 2018
End Date
March 23 2022
Last Update
September 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philippe GUILBERT
Reims, France, 51100